Abstract
1½ month old child born to primigravida mother on prolonged carbamazepine therapy presented with recurrent seizures. The child had abnormal facies and was diagnosed to be having arteriovenous malformation with intracranial hemorrhage on neuroimaging. This case suggests that development of arteriovenous malformation in a child with maternal carbamazepine therapy may occur as a part of clinical profile of ‘fetal anticonvulsant syndrome’.
Similar content being viewed by others
References
Crawford P. Best practice guidelines for the management of women with epilepsy. Epilepsia 2005; 46(Suppl 9): 117–124.
Yerby MS, Leavitt A, EricKson B, McComick KB, Loewenson RB, Sells CJ et al. Antiepileptic drugs and the development of congenital anomalies. Neurology 1992; 42: 132–140.
Artama M, Auvineu A, Raudaskoski T, Isojarvi I, Isojarvi J. Antiepileptic drug use of women with epilepsy and congenital malformations in offspring. Neurology 2005; 64: 1874–1878.
Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989; 320: 1661–1666.
Gupta G, Bansal A, Singh M. Antenatal Carbamazepine use associated with d-TGA and ASD. Indian Pediatr 2002; 39: 101–102.
Halem RHA. The nervous system: Intracerebral hemorrhage. In Behrman, Kliegman, Jenson, eds. Nelson Textbook of Pediatrics. Philadelphia; WB Saunders Co; 1999; 1856.
Lindhout D, Hoppener RJ, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984; 25: 77–83.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Narang, M., Shah, D. & Natasha, G. Intracranial arteriovenous malformation with maternal carbamazepine use. Indian J Pediatr 74, 85–86 (2007). https://doi.org/10.1007/s12098-007-0035-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12098-007-0035-9